Skip to content

Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications

Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01463904
Acronym
SADI-S 250
Enrollment
250
Registered
2011-11-02
Start date
2007-04-30
Completion date
2015-04-30
Last updated
2011-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Morbid Obesity

Keywords

Morbid obesity, duodenal switch, diabetes, decrease in cardiac risk, remission of T2DM

Brief summary

Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy is a modified and simplified duodenal switch. It is performed on morbid obese patients and severe T2DM patients with obesity, and a proper weight loss is expected as well as a decrease in the cardiac risk and a remission of T2DM. A lower complication rate than for duodenal switch is expected.

Detailed description

A sleeve gastrectomy over a wide bougie is performed. Then the proximal duodenum is divided and anastomosed to the ileum 250 cm from the cecum. The preoperative studies and postoperative follow up is similar to those performed before and after other bariatric procedures.

Interventions

PROCEDURESADI-S 250

Single-Anastomosis Duodeno-Ileal bypass with Sleeve gastrectomy

Sponsors

Hospital San Carlos, Madrid
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \> 30 with T2DM or BMI \> 40

Exclusion criteria

* Oncologic patients, alcoholic patients, mentally retarded

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026